TRPA1 Inhibition Effects by 3-Phenylcoumarin Derivatives

Carita Sallomy, Paul Awolade, Minna Rahnasto-Rilla, Mari Hämäläinen, Liisa P. Nousiainen, Niklas G. Johansson, Sanna Hiltunen, Petri Turhanen, Eeva Moilanen, Maija Lahtela-Kakkonen, Juri M. Timonen

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Abstrakti

Transient receptor potential ankyrin 1 (TRPA1) protein plays an important role in the inflammatory response, and it has been associated with different pain conditions and pain-related diseases, making TRPA1 a valid target for painkillers. In this study, we identified potential TRPA1 inhibitors and located their binding sites utilizing computer-aided drug design (CADD) techniques. The designed 3-phenylcoumarin-based TRPA1 inhibitors were successfully synthesized using a microwave assisted synthetic strategy. 3-(3-Bromophenyl)-7-acetoxycoumarin (5), 7-hydroxy-3-(3-hydroxyphenyl)coumarin (12) and 3-(3-hydroxyphenyl)coumarin (23) all showed inhibitory activity toward TRPA1 in vitro. Compound 5 also decreased the size and formation of breast cancer cells. Hence, targeting TRPA1 may represent a promising alternative for the treatment of pain and inflammation.

Alkuperäiskielienglanti
LehtiACS Medicinal Chemistry Letters
ISSN1948-5875
DOI - pysyväislinkit
TilaJulkaistu - 2 heinäk. 2024
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Lisätietoja

Publisher Copyright:
© 2024 American Chemical Society.

Tieteenalat

  • 116 Kemia

Siteeraa tätä